We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+24.81%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$18.7B
AUM Growth
+$4.8B
(+35%)
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
1,702
New
548
Increased
855
Reduced
264
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$140M |
| 2 |
Microsoft
MSFT
|
+$124M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Carrier Global
CARR
|
+$94.7M |
| 5 |
Otis Worldwide
OTIS
|
+$88.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$47.8M |
| 2 |
Abbott
ABT
|
+$25.1M |
| 3 |
Colgate-Palmolive
CL
|
+$24.3M |
| 4 |
Hormel Foods
HRL
|
+$23.2M |
| 5 |
Walmart Inc
WMT
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.9% |
| 2 | Consumer Discretionary | 13.41% |
| 3 | Industrials | 11.79% |
| 4 | Financials | 10.2% |
| 5 | Healthcare | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Kinsale Capital Group
KNSL
$7.95B
| $493K | ﹤0.01% |
+3,177
| New | +$423K |
|
952
NeoGenomics
NEO
$1.81B
| $493K | ﹤0.01% |
15,920
+8,654
| +119% | +$240K |
|
953
XPO
XPO
$25B
| $493K | ﹤0.01% |
+18,459
| New | +$442K |
|
954
Azenta
AZTA
$1.26B
| $491K | ﹤0.01% |
+11,109
| New | +$425K |
|
955
Kennametal
KMT
$2.68B
| $491K | ﹤0.01% |
+17,097
| New | +$436K |
|
956
Fox Factory Holding Corp
FOXF
$776M
| $489K | ﹤0.01% |
+5,925
| New | +$369K |
|
|
WPX
957
DELISTED
WPX Energy, Inc.
WPX
| $488K | ﹤0.01% |
76,566
+32,254
| +73% | +$182K |
|
958
Ironwood Pharmaceuticals
IRWD
$611M
| $487K | ﹤0.01% |
47,154
+16,428
| +53% | +$168K |
|
959
Penumbra
PEN
$12.5B
| $486K | ﹤0.01% |
2,719
+955
| +54% | +$166K |
|
960
Affiliated Managers Group
AMG
$9.46B
| $485K | ﹤0.01% |
6,503
+1,556
| +31% | +$105K |
|
|
CIM
961
Chimera Investment
CIM
$1.05B
| $485K | ﹤0.01% |
16,814
+9,669
| +135% | +$248K |
|
962
Editas Medicine
EDIT
$399M
| $483K | ﹤0.01% |
16,326
+6,240
| +62% | +$163K |
|
963
Service Corp International
SCI
$11.4B
| $482K | ﹤0.01% |
12,397
+4,912
| +66% | +$189K |
|
|
JMIA
964
Jumia Technologies
JMIA
$726M
| $481K | ﹤0.01% |
87,633
+60,237
| +220% | +$278K |
|
965
Twist Bioscience
TWST
$5.62B
| $480K | ﹤0.01% |
+10,607
| New | +$381K |
|
966
Repligen
RGEN
$7.44B
| $479K | ﹤0.01% |
3,875
-1,739
| -31% | -$205K |
|
967
Yeti Holdings
YETI
$3.82B
| $479K | ﹤0.01% |
+11,202
| New | +$337K |
|
968
Ryman Hospitality Properties
RHP
$8.4B
| $478K | ﹤0.01% |
13,813
+4,742
| +52% | +$157K |
|
969
Terreno Realty
TRNO
$7.68B
| $477K | ﹤0.01% |
+9,064
| New | +$470K |
|
|
ADVM
970
DELISTED
Adverum Biotechnologies
ADVM
| $475K | ﹤0.01% |
2,276
+1,026
| +82% | +$182K |
|
971
Hubbell
HUBB
$25.7B
| $475K | ﹤0.01% |
3,790
+1,605
| +73% | +$195K |
|
|
NVTA
972
DELISTED
Invitae Corporation
NVTA
| $475K | ﹤0.01% |
+15,688
| New | +$274K |
|
|
CZR
973
DELISTED
Caesars Entertainment Corporation
CZR
| $474K | ﹤0.01% |
39,103
+16,175
| +71% | +$163K |
|
974
Cannae Holdings
CNNE
$647M
| $473K | ﹤0.01% |
+11,510
| New | +$394K |
|
975
Natera
NTRA
$37.5B
| $473K | ﹤0.01% |
+9,481
| New | +$381K |
|
Similar funds
ProShare Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, ProShare Advisors held 1,702 positions worth $18.7B, up 35% from $13.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
ProShare Advisors deployed $1.69B of net new capital in Q2 2020, opening 548 new positions and adding to 855 existing holdings. Its largest new stake was Carrier Global: 5,097,223 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Clorox, an estimated $47.8M trimmed.
- ProShare Advisors's largest Q2 2020 buy was Carrier Global: 5,097,223 shares worth $113M.
- ProShare Advisors added most to Amazon in Q2 2020, an estimated $140M increase.
- ProShare Advisors's biggest Q2 2020 reduction was Clorox, cutting an estimated $47.8M.
- ProShare Advisors fully exited Utah Medical Products in Q2 2020, selling an estimated $11.6M.
- ProShare Advisors's ten largest holdings make up 24% of its $18.7B portfolio in Q2 2020.
- ProShare Advisors opened 548 new positions and closed 34 in Q2 2020.
- ProShare Advisors's portfolio value rose 35% quarter-over-quarter to $18.7B.
Based on ProShare Advisors's 13F filing for Q2 2020, filed 3 Aug 2020.